Life scientists identify drug that could aid treatment of anxiety disorders

by Stuart Wolpert

(Medical Xpress)—The drug scopolamine has been used to treat a variety of conditions, including nausea and motion sickness. A new study by UCLA life scientists suggests that it may also be useful in treating anxiety disorders.

Researchers found that the drug can help boost the effectiveness of a common treatment for known as exposure therapy. In exposure therapy, a subject with a phobia or anxiety is repeatedly exposed to the object or situation they fear, in a non-threatening setting. The goal of this treatment is to ultimately lessen and eliminate the fear — in essence, make it "extinct."

However, fear- memories formed during this type of therapy tend to be weak because they are tied to the non-dangerous context. Subjects have a tendency to relapse when they again encounter the source of their anxiety in a different environment.

"Extinction has one Achilles heel that at present has not quite been pierced — namely, extinction learning is highly dependent on the environment or context in which it occurs," said Michael Fanselow, a UCLA professor of psychology and the senior author of the study. "This makes memories formed during extinction highly fragile and susceptible to fear-recovery or relapse in any non-extinction environment."

In their new study, published Feb. 15 in the in the journal Biological Psychiatry, Fanselow and his colleagues attempted to overcome this challenge by administering in conjunction with the exposure therapy.

"We took an entirely novel by targeting extinctions' context-dependency and attempting to unbind extinction from its contextual bond," said Fanselow, who holds UCLA's Eleanor Leslie Term Chair in Innovative Neuroscience. "Using a non-invasive and readily translatable pharmacological agent, scopolamine, to block cholinergic transmission and hence, contextual processing, we discovered that fear-recovery after extinction could be thwarted."

Fanselow and his team were able to disrupt contextual processing in rats during anxiety-extinction by using low doses of the drug.

"This finding provides groundbreaking evidence that changing the nature of extinction learning, rather then its magnitude, can produce profound improvements in the prevention of relapse," Fanselow said.

The research, while still preliminary, suggests that scopolamine may be an effective pharmacological adjunct to .

Related Stories

Treating addiction by eliminating drug-associated memories

Apr 23, 2009

Addicts, even those who have been abstinent for long periods of time, are often still vulnerable to their own memories of prior drug use.  For example, exposure to the same environment in which they commonly used drugs - ...

Recommended for you

Study: Pupil size shows reliability of decisions

6 hours ago

Te precision with which people make decisions can be predicted by measuring pupil size before they are presented with any information about the decision, according to a new study published in PLOS Computational Bi ...

Single dose of antidepressant changes the brain

9 hours ago

A single dose of antidepressant is enough to produce dramatic changes in the functional architecture of the human brain. Brain scans taken of people before and after an acute dose of a commonly prescribed ...

User comments